Partner: A. Mackiewicz |
Recent publications
1. | Gabriele V.R.♦, Mazhabi R.M.♦, Alexander N.♦, Mukherjee P.♦, Seyfried T.N.♦, Nwaji N.♦, Akinoglu E.M.♦, Mackiewicz A.♦, Zhou G.♦, Giersig M., Naughton M.J.♦, Kempa K.♦, Light- and melanin nanoparticle-induced cytotoxicity in metastatic cancer cells, Pharmaceutics, ISSN: 1999-4923, DOI: 10.3390/pharmaceutics13070965, Vol.13, No.7, pp.965-1-14, 2021 Abstract: Melanin nanoparticles are known to be biologically benign to human cells for a wide range of concentrations in a high glucose culture nutrition. Here, we show cytotoxic behavior at high nanoparticle and low glucose concentrations, as well as at low nanoparticle concentration under exposure to (nonionizing) visible radiation. To study these effects in detail, we developed highly monodispersed melanin nanoparticles (both uncoated and glucose-coated). In order to study the effect of significant cellular uptake of these nanoparticles, we employed three cancer cell lines: VM-M3, A375 (derived from melanoma), and HeLa, all known to exhibit strong macrophagic character, i.e., strong nanoparticle uptake through phagocytic ingestion. Our main observations are: (i) metastatic VM-M3 cancer cells massively ingest melanin nanoparticles (mNPs); (ii) the observed ingestion is enhanced by coating mNPs with glucose; (iii) after a certain level of mNP ingestion, the metastatic cancer cells studied here are observed to die—glucose coating appears to slow that process; (iv) cells that accumulate mNPs are much more susceptible to killing by laser illumination than cells that do not accumulate mNPs; and (v) non-metastatic VM-NM1 cancer cells also studied in this work do not ingest the mNPs, and remain unaffected after receiving identical optical energy levels and doses. Results of this study could lead to the development of a therapy for control of metastatic stages of cancer. Keywords:melanoma, melanin nanoparticles, cytotoxicity, laser medical applications, hyperthermia Affiliations:
| |||||||||||||||||||||||||||||||||||||
2. | Kucharczyk K.♦, Rybka J.D.♦, Hilgendorff M.♦, Krupinski M.♦, Slachcinski M.♦, Mackiewicz A.♦, Giersig M.♦, Dams-Kozlowska H.♦, Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications, PLOS ONE, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0219790, Vol.14, No.7, pp. e0219790-1-20, 2019 Abstract: Bioengineered spider silk is a biomaterial that has exquisite mechanical properties, biocompatibility, and biodegradability. Iron oxide nanoparticles can be applied for the detection and analysis of biomolecules, target drug delivery, as MRI contrast agents and as therapeutic agents for hyperthermia-based cancer treatments. In this study, we investigated three bioengineered silks, MS1, MS2 and EMS2, and their potential to form a composite material with magnetic iron oxide nanoparticles (IONPs). The presence of IONPs did not impede the self-assembly properties of MS1, MS2, and EMS2 silks, and spheres formed. The EMS2 spheres had the highest content of IONPs, and the presence of magnetite IONPs in these carriers was confirmed by several methods such as SEM, EDXS, SQUID, MIP-OES and zeta potential measurement. The interaction of EMS2 and IONPs did not modify the superparamagnetic properties of the IONPs, but it influenced the secondary structure of the spheres. The composite particles exhibited a more than two-fold higher loading efficiency for doxorubicin than the plain EMS2 spheres. For both the EMS2 and EMS2/IONP spheres, the drug revealed a pH-dependent release profile with advantageous kinetics for carriers made of the composite material. The composite spheres can be potentially applied for a combined cancer treatment via hyperthermia and drug delivery. Affiliations:
|